Nisa Investment Advisors
SBBP

Nisa Investment Advisors’s Strongbridge Biopharma plc. SBBP Stock Holding History

Nisa Investment Advisors’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,159
Closed -$12K – 2131
2020
Q1 		$12K Hold
6,159
– – ﹤0.01% 1828
2019
Q4 		$13K Hold
6,159
– – ﹤0.01% 1791
2019
Q3 		$15K Buy
+6,159
New +$16.5K ﹤0.01% 1691

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nisa Investment Advisors's SBBP Position: Q2 2020 in Review

Nisa Investment Advisors sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2020, closing a stake of 6,159 shares — an estimated $12K sold.

Nisa Investment Advisors first reported a position in SBBP in Q3 2019 and held it in 3 quarters. The position peaked at $15K in Q3 2019. 69 funds tracked by Wall St. Rank hold SBBP as of Q2 2020.

  • Nisa Investment Advisors reported no remaining Strongbridge Biopharma plc. position as of Q2 2020 after selling out during the quarter.
  • Nisa Investment Advisors sold 6,159 Strongbridge Biopharma plc. shares in Q2 2020, an estimated $12K.
  • Nisa Investment Advisors first reported a position in Strongbridge Biopharma plc. in Q3 2019 and held it in 3 quarters.
  • Nisa Investment Advisors's Strongbridge Biopharma plc. position peaked at $15K in Q3 2019.
  • 69 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2020.

Based on Nisa Investment Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.